Portage Biotech Inc [NASDAQ: PRTG] surged by $4.89 during the normal trading session on while it closed the day at $9.60.
Portage Biotech Inc stock has also gained 131.33% of its value over the past 7 days. However, PRTG stock has inclined by 84.97% in the 3 months of the year. Over the past six months meanwhile, it has gained 37.73% and gained 85.69% year-on date.
The market cap for PRTG stock reached $10.76 million, with 1.12 million shares outstanding and 0.16 million shares in the current float. Compared to the average trading volume of 101.95K shares, PRTG reached a trading volume of 29799873 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Portage Biotech Inc [PRTG]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PRTG shares is $140.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PRTG stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Portage Biotech Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 18, 2022. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on March 07, 2022, representing the official price target for Portage Biotech Inc stock. Previously, the target price had yet another raise to $30, while Oppenheimer analysts kept a Outperform rating on PRTG stock.
The Average True Range (ATR) for Portage Biotech Inc is set at 0.98 The Price to Book ratio for the last quarter was 7.67, with the Price to Cash per share for the same quarter was set at 1.57.
PRTG stock trade performance evaluation
Portage Biotech Inc [PRTG] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 131.33. With this latest performance, PRTG shares gained by 121.20% in over the last four-week period, additionally plugging by 37.73% over the last 6 months – not to mention a drop of -9.43% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PRTG stock in for the last two-week period is set at 87.24, with the RSI for the last a single of trading hit 92.61, and the three-weeks RSI is set at 81.25 for Portage Biotech Inc [PRTG]. The present Moving Average for the last 50 days of trading for this stock 4.51, while it was recorded at 5.42 for the last single week of trading, and 4.69 for the last 200 days.
Portage Biotech Inc [PRTG]: An insightful look at the core fundamentals
Portage Biotech Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.08 and a Current Ratio set at 3.08.
Portage Biotech Inc [PRTG]: Institutional Ownership
There are presently around $6.20%, or 12.74%% of PRTG stock, in the hands of institutional investors. The top three institutional holders of PRTG stocks are: ARMISTICE CAPITAL, LLC with ownership of 1.5 million shares, which is approximately 7.1866%., holding 0.3 million shares of the stock with an approximate value of $$71514.0 in PRTG stocks shares; and, currently with $$0.12 million in PRTG stock with ownership which is approximately 1.0212%.
